{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:12:45Z","timestamp":1781521965827,"version":"3.54.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA045244"],"award-info":[{"award-number":["DA045244"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.mcna.2021.08.011","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T21:59:02Z","timestamp":1637618342000},"page":"99-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Tobacco Use Disorder"],"prefix":"10.1016","volume":"106","author":[{"given":"Frank T.","family":"Leone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Evers-Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mcna.2021.08.011_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10722-006-0024-2","article-title":"Aspects of the evolution of Nicotiana tabacum L. and the status of the United States Nicotiana Germplasm Collection","volume":"54","author":"Lewis","year":"2007","journal-title":"Genet Resour Crop Evol"},{"key":"10.1016\/j.mcna.2021.08.011_bib2","first-page":"313","article-title":"Plant-derived stimulants and psychoactive substances -social and economic aspects","volume":"5","author":"\u0106wintal","year":"2020","journal-title":"J Med Clin Res Rev"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib3","first-page":"5","article-title":"Monograph of Tobacco (Nicotiana tabacum)","volume":"2","author":"Kishore","year":"2014","journal-title":"Indian J Drugs"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.011_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12639-014-0550-3","article-title":"In vitro anthelmintic effect of Tobacco (Nicotiana tabacum) extract on parasitic nematode, Marshallagia marshalli","volume":"40","author":"Nouri","year":"2016","journal-title":"J Parasit Dis"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.33493\/scivis.19.01.04","article-title":"A review on tobacco and its effect on health","volume":"19","author":"Lalruatfela","year":"2019","journal-title":"Sci Vis"},{"key":"10.1016\/j.mcna.2021.08.011_bib6","series-title":"WHO global report on trends in prevalence of tobacco smoking","author":"World Health Organization","year":"2015"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.011_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1215\/00021482-77.4.527","article-title":"Slavery and American Agricultural History","volume":"77","author":"Wright","year":"2003","journal-title":"Agric Hist"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2307\/3111987","article-title":"Origins of the American Tobacco Company","volume":"43","author":"Porter","year":"1969","journal-title":"Bus Hist Rev"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1513\/AnnalsATS.201312-428ED","article-title":"The emergence of E-cigarettes: a triumph of wishful thinking over Science","volume":"11","author":"Leone","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.mcna.2021.08.011_bib10","author":"Farnsworth"},{"key":"10.1016\/j.mcna.2021.08.011_bib11","series-title":"Effect of Potassium on the Production and Quality of tobacco Leaves","author":"Marchand","year":"2010"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.011_bib12","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.2105\/AJPH.2007.121657","article-title":"The secret and soul of Marlboro","volume":"98","author":"Stevenson","year":"2008","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1037\/a0035749","article-title":"Nicotine-like behavioral effects of the minor tobacco alkaloids nornicotine, anabasine, and anatabine in male rodents","volume":"22","author":"Caine","year":"2014","journal-title":"Exp Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.011_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/chromsci\/13.4.159","article-title":"Chemical studies on tobacco smoke XXXIV. gas chromatographic determination of ammonia in cigarette and cigar smoke","volume":"13","author":"Brunnemann","year":"1975","journal-title":"J Chromatogr Sci"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/1462220042000202472","article-title":"Ammonia and other chemical base tobacco additives and cigarette nicotine delivery: Issues and research needs","volume":"6","author":"Henningfield","year":"2004","journal-title":"Nicotine Tob Res"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.011_bib16","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1021\/es970402f","article-title":"Conversion of nicotine in tobacco smoke to its volatile and available free-base form through the action of gaseous ammonia","volume":"31","author":"Pankow","year":"1997","journal-title":"Environ Sci Technol"},{"issue":"12","key":"10.1016\/j.mcna.2021.08.011_bib17","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1016\/j.fct.2011.09.037","article-title":"Effect of ammonia in cigarette tobacco on nicotine absorption in human smokers","volume":"49","author":"van Amsterdam","year":"2011","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2004.08.043","article-title":"Nicotine increases in vivo blood\u2013brain barrier permeability and alters cerebral microvascular tight junction protein distribution","volume":"1027","author":"Hawkins","year":"2004","journal-title":"Brain Res"},{"issue":"9","key":"10.1016\/j.mcna.2021.08.011_bib19","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1248\/bpb.b18-00134","article-title":"Impact of nicotine transport across the blood\u2013brain barrier: carrier-mediated transport of nicotine and interaction with central nervous system drugs","volume":"41","author":"Tega","year":"2018","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.011_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1176\/appi.ajp.163.3.359","article-title":"Stimulant medications: how to minimize their reinforcing effects?","volume":"163","author":"Volkow","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.physbeh.2011.11.004","article-title":"Allostasis and addiction: Role of the dopamine and corticotropin-releasing factor systems","volume":"106","author":"George","year":"2012","journal-title":"Physiol Behav"},{"key":"10.1016\/j.mcna.2021.08.011_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2010.02.014","article-title":"Regulation of the nicotinic receptor alpha7 subunit by chronic stress and corticosteroids","volume":"1325","author":"Hunter","year":"2010","journal-title":"Brain Res"},{"issue":"1\u20132","key":"10.1016\/j.mcna.2021.08.011_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-8993(94)90401-4","article-title":"Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area","volume":"653","author":"Corrigall","year":"1994","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.011_bib24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1523\/JNEUROSCI.4542-05.2006","article-title":"Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area","volume":"26","author":"Ikemoto","year":"2006","journal-title":"J Neurosci"},{"issue":"18","key":"10.1016\/j.mcna.2021.08.011_bib25","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.1523\/JNEUROSCI.5671-10.2011","article-title":"Nicotine potentiation of excitatory inputs to ventral tegmental area dopamine neurons","volume":"31","author":"Mao","year":"2011","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/CPM.0b013e318247cada","article-title":"Developing a rational approach to tobacco use treatment in pulmonary practice","volume":"19","author":"Leone","year":"2012","journal-title":"Clin Pulm Med"},{"issue":"14","key":"10.1016\/j.mcna.2021.08.011_bib27","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0024-3205(79)90469-7","article-title":"Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: Effect of nicotine in a low concentration","volume":"25","author":"Giorguieff-Chesselet","year":"1979","journal-title":"Life Sci"},{"issue":"5\u20136","key":"10.1016\/j.mcna.2021.08.011_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.neuropharm.2009.07.033","article-title":"Nicotine differentially affects dopamine transmission in the nucleus accumbens shell and core of Lewis and Fischer 344 rats","volume":"57","author":"Cadoni","year":"2009","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.011_bib29","first-page":"1188","article-title":"Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors","volume":"284","author":"Fu","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.011_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.011_bib31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/cercor\/10.3.318","article-title":"Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex","volume":"10","author":"Volkow","year":"2000","journal-title":"Cereb Cortex"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.011_bib32","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/npp.2009.11","article-title":"Nucleus accumbens CREB activity is necessary for nicotine conditioned place preference","volume":"34","author":"Brunzell","year":"2009","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.mcna.2021.08.011_bib33","author":"Kaste"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.011_bib34","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMsa1405092","article-title":"A molecular basis for nicotine as a gateway drug","volume":"371","author":"Kandel","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0304-3940(90)90491-Q","article-title":"Nicotine protects against \u03bc-opioid receptor antagonism by \u03b2-funaltrexamine: Evidence for nicotine-induced release of endogenous opioids in brain","volume":"113","author":"Davenport","year":"1990","journal-title":"Neurosci Lett"},{"issue":"6068","key":"10.1016\/j.mcna.2021.08.011_bib36","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1126\/science.1218170","article-title":"Neuroscience. To stop or not to stop?","volume":"335","author":"Volkow","year":"2012","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.15585\/mmwr.mm6702a1","article-title":"Current cigarette smoking among adults \u2014 United States, 2016","volume":"67","author":"Jamal","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.011_bib39","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/tc.10.3.210","article-title":"Poverty and tobacco","volume":"10","author":"Beyer","year":"2001","journal-title":"Tob Control"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1465-3362.2010.00202.x","article-title":"Association between concurrent alcohol and tobacco use and poverty","volume":"30","author":"Silva","year":"2011","journal-title":"Drug Alcohol Rev"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/tobaccocontrol-2011-050181","article-title":"A systematic review of the aetiology of tobacco disparities for sexual minorities","volume":"22","author":"Blosnich","year":"2013","journal-title":"Tob Control"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.011_bib42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/tc.2008.028241","article-title":"Tobacco use among sexual minorities in the USA, 1987 to May 2007: a systematic review","volume":"18","author":"Lee","year":"2009","journal-title":"Tob Control"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/0033354918824330","article-title":"The influence of tobacco retailer density and poverty on tobacco use in a densely populated urban environment","volume":"134","author":"Farley","year":"2019","journal-title":"Public Health Rep"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1037\/0021-843X.116.2.249","article-title":"Inattention as a key predictor of tobacco use in adolescence","volume":"116","author":"Burke","year":"2007","journal-title":"J Abnorm Psychol"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.011_bib45","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/gps.4382","article-title":"Prevalence and predictors of tobacco use in the elderly","volume":"31","author":"Pang","year":"2016","journal-title":"Int J Geriatr Psychiatry"},{"issue":"45","key":"10.1016\/j.mcna.2021.08.011_bib46","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.15585\/mmwr.mm6745a5","article-title":"Notes from the field: use of electronic cigarettes and any tobacco product among middle and high school students \u2014 United States, 2011\u20132018","volume":"67","author":"Cullen","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"issue":"30","key":"10.1016\/j.mcna.2021.08.011_bib47","first-page":"8","article-title":"Is e-cigarette use in non-smoking young adults associated with later smoking? A systematic review and meta-analysis","volume":"10","author":"Khouja","year":"2020","journal-title":"Tob Control"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib48","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1186\/s12889-021-10935-1","article-title":"Association between electronic cigarette use and tobacco cigarette smoking initiation in adolescents: a systematic review and meta-analysis","volume":"21","author":"O\u2019Brien","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.mcna.2021.08.011_bib49","series-title":"Office on smoking and Health. The Health Consequences of smoking\u201450 Years of Progress: a report of the Surgeon general","year":"2014"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.011_bib50","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.2105\/AJPH.2012.301112","article-title":"Undertreatment of tobacco use relative to other chronic conditions","volume":"103","author":"Bernstein","year":"2013","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41533-017-0038-6","article-title":"Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study","volume":"27","author":"van Eerd","year":"2017","journal-title":"Npj Prim Care Respir Med"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.011_bib52","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1513\/AnnalsATS.201410-467BC","article-title":"Behavioral economic insights into physician tobacco treatment decision-making","volume":"12","author":"Leone","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.011_bib53","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1513\/AnnalsATS.201410-466BC","article-title":"Academic detailing interventions improve tobacco use treatment among physicians working in underserved communities","volume":"12","author":"Leone","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"12","key":"10.1016\/j.mcna.2021.08.011_bib54","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1037\/hea0000784","article-title":"Implicit attribution of culpability and impact on experience of treating tobacco dependence","volume":"38","author":"Evers-Casey","year":"2019","journal-title":"Health Psychol"},{"key":"10.1016\/j.mcna.2021.08.011_bib55","series-title":"The Health Consequences of smoking: Nicotine Addiction: a report of the Surgeon general","year":"1988"},{"key":"10.1016\/j.mcna.2021.08.011_bib56","series-title":"Smoking cessation. Clinical Practice Guideline, Number 18","author":"Fiore","year":"1996"},{"key":"10.1016\/j.mcna.2021.08.011_bib57","series-title":"Treating tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline","author":"Fiore","year":"2008"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.011_bib58","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1513\/AnnalsATS.201802-099PS","article-title":"Nicotine dependence: future opportunities and emerging clinical challenges","volume":"15","author":"Leone","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib59","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1164\/rccm.202005-1982ST","article-title":"Initiating pharmacologic treatment in tobacco-dependent adults. An Official American Thoracic Society Clinical Practice Guideline","volume":"202","author":"Leone","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"25","key":"10.1016\/j.mcna.2021.08.011_bib60","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.jacc.2018.10.027","article-title":"2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents","volume":"72","author":"Barua","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2021.08.011_bib61","author":"Sachs"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.011_bib62","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.pop.2009.04.002","article-title":"Behavioral Interventions in Tobacco Dependence","volume":"36","author":"Leone","year":"2009","journal-title":"Prim Care Clin"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.011_bib63","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/ntr\/nty250","article-title":"The network structure of tobacco withdrawal in a community sample of smokers treated with nicotine patch and behavioral counseling","volume":"22","author":"Lydon-Staley","year":"2020","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib64","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41386-020-00805-6","article-title":"Modeling brain, symptom, and behavior in the winds of change","volume":"46","author":"Lydon-Staley","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib65","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/1462220031000073252","article-title":"Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting","volume":"5","author":"Croghan","year":"2003","journal-title":"Nicotine Tob Res"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.011_bib66","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1056\/NEJMcp012279","article-title":"Clinical practice. Treatment of tobacco use and dependence","volume":"346","author":"Rigotti","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/ntr\/nts141","article-title":"Assigning Dose of Nicotine Gum by Time to First Cigarette","volume":"15","author":"Shiffman","year":"2013","journal-title":"Nicotine Tob Res"},{"issue":"11","key":"10.1016\/j.mcna.2021.08.011_bib68","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archinte.162.11.1267","article-title":"Efficacy of a nicotine lozenge for smoking cessation","volume":"162","author":"Shiffman","year":"2002","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.011_bib69","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.addbeh.2006.06.021","article-title":"Physicians\u2019 counseling of patients when prescribing nicotine replacement therapy","volume":"32","author":"Shiffman","year":"2007","journal-title":"Addict Behav"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib70","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","article-title":"Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial","volume":"121","author":"Rigotti","year":"2010","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.mcna.2021.08.011_bib71","doi-asserted-by":"crossref","first-page":"e009424","DOI":"10.1161\/JAHA.118.009424","article-title":"Short-term safety of nicotine replacement in smokers hospitalized with coronary heart disease","volume":"7","author":"Pack","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.011_bib72","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF02245429","article-title":"Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study","volume":"106","author":"Foulds","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.011_bib73","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4088\/PCC.v06n0403","article-title":"A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor","volume":"6","author":"Stahl","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.011_bib74","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2165\/00003495-200059040-00019","article-title":"Bupropion: a review of its use in the management of smoking cessation","volume":"59","author":"Holm","year":"2000","journal-title":"Drugs"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2021.08.011_bib75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-200262002-00003","article-title":"Clinical efficacy of bupropion in the management of smoking cessation","volume":"62","author":"Jorenby","year":"2002","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.011_bib76","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/ntr\/ntp042","article-title":"Combination treatment with varenicline and nicotine replacement therapy","volume":"11","author":"Ebbert","year":"2009","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jama.2014.7195","article-title":"Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial","volume":"312","author":"Koegelenberg","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib78","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/clpt.2011.317","article-title":"The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial","volume":"91","author":"Hawk","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.011_bib79","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/archinternmed.2011.138","article-title":"Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates","volume":"171","author":"Hajek","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2021.08.011_bib80","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/pr.57.1.3","article-title":"Metabolism and Disposition Kinetics of Nicotine","volume":"57","author":"Hukkanen","year":"2005","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib82","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00213-011-2341-1","article-title":"Systematic review of the relationship between the 3-hydroxycotinine\/cotinine ratio and cigarette dependence","volume":"218","author":"West","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.011_bib83","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/14622200701239605","article-title":"An association of CYP2A6 genotype and smoking topography","volume":"9","author":"Strasser","year":"2007","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib84","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pbb.2008.10.016","article-title":"Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study","volume":"92","author":"Schnoll","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.011_bib85","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11481-016-9656-y","article-title":"Precision medicine for tobacco dependence: development and validation of the nicotine metabolite ratio","volume":"11","author":"Allenby","year":"2016","journal-title":"J Neuroimmune Pharmacol"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.011_bib86","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1158\/1940-6207.CAPR-19-0259","article-title":"The use of the nicotine metabolite ratio as a biomarker to personalize smoking cessation treatment: current evidence and future directions","volume":"13","author":"Siegel","year":"2020","journal-title":"Cancer Prev Res Phila Pa"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.011_bib87","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.clpt.2006.02.006","article-title":"Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation","volume":"79","author":"Lerman","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.011_bib88","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S2213-2600(14)70294-2","article-title":"Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial","volume":"3","author":"Lerman","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.011_bib89","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2217\/bmm.11.91","article-title":"Biomarkers to optimize the treatment of nicotine dependence","volume":"5","author":"Schnoll","year":"2011","journal-title":"Biomark Med"},{"issue":"10","key":"10.1016\/j.mcna.2021.08.011_bib90","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1513\/AnnalsATS.201802-099PS","article-title":"Nicotine dependence: future opportunities and emerging clinical challenges","volume":"15","author":"Leone","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib91","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/14622200412331328466","article-title":"Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain","volume":"7","author":"Pomerleau","year":"2005","journal-title":"Nicotine Tob Res"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.011_bib92","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/ntr\/ntz232","article-title":"Characterization of nicotine salts in 23 electronic cigarette refill liquids","volume":"22","author":"Harvanko","year":"2020","journal-title":"Nicotine Tob Res"},{"issue":"12","key":"10.1016\/j.mcna.2021.08.011_bib93","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1080\/17425247.2020.1814736","article-title":"Nicotine forms: why and how do they matter in nicotine delivery from electronic cigarettes?","volume":"17","author":"Gholap","year":"2020","journal-title":"Expert Opin Drug Deliv"},{"issue":"0","key":"10.1016\/j.mcna.2021.08.011_bib94","first-page":"1","article-title":"Potential factors affecting free base nicotine yield in electronic cigarette aerosols","volume":"0","author":"Gholap","year":"2021","journal-title":"Expert Opin Drug Deliv"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.011_bib95","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/tobaccocontrol-2018-054565","article-title":"High exposure to nicotine among adolescents who use Juul and other vape pod systems (\u2018pods\u2019)","volume":"28","author":"Goniewicz","year":"2019","journal-title":"Tob Control"},{"key":"10.1016\/j.mcna.2021.08.011_bib96","author":"Neto"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.011_bib97","first-page":"1933","article-title":"Closing the regulatory gap for synthetic nicotine products","volume":"59","author":"Zettler","year":"2018","journal-title":"Boston Coll Law Rev"},{"issue":"11","key":"10.1016\/j.mcna.2021.08.011_bib98","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/nn1105-1431","article-title":"Neurobiology of addiction: treatment and public policy ramifications","volume":"8","author":"Dackis","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.mcna.2021.08.011_bib99","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.socscimed.2015.09.026","article-title":"The downside of tobacco control? Smoking and self-stigma: A systematic review","volume":"145","author":"Evans-Polce","year":"2015","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.011_bib100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1017\/S004727941100033X","article-title":"Smoking, Stigma and Social Class","volume":"41","author":"Graham","year":"2012","journal-title":"J Soc Policy"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.011_bib101","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jtho.2021.03.010","article-title":"Critical determinants of cancer treatment outcomes: smoking must be addressed at the highest levels in cancer care","volume":"16","author":"Warren","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.011_bib102","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jtho.2020.12.017","article-title":"Smoking behavior in patients with early-stage NSCLC: a report from ECOG-ACRIN 1505 trial","volume":"16","author":"Steuer","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.011_bib103","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jtho.2021.02.024","article-title":"Tobacco smoking and risk of second primary lung cancer","volume":"16","author":"Aredo","year":"2021","journal-title":"J Thorac Oncol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571252100119X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571252100119X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T19:44:29Z","timestamp":1672343069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002571252100119X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S002571252100119X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.08.011","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tobacco Use Disorder","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}